← Back to guidelines
Cardiology3 papers

Adamantinoma of long bones

Last edited: 4/23/2026

Overview

Adamantinoma of long bones is a rare, low-grade malignant neoplasm primarily affecting the tibia and fibula, characterized by its distinctive histological features including epithelial and mesenchymal differentiation. 1 does not directly address adamantinoma but provides context on surgical interventions in long bones.

Diagnosis

  • Imaging studies (CT, MRI) essential for initial evaluation and staging.
  • Definitive diagnosis requires histopathological examination with immunohistochemistry.
  • Bone scans may show increased uptake due to bone remodeling.
  • Management

  • Surgical resection with wide margins is the cornerstone of treatment.
  • Intramedullary nailing or plate fixation may be used for stabilization post-resection 1.
  • Adjuvant radiotherapy considered in cases with high risk of recurrence or incomplete resection.
  • Chemotherapy typically not indicated unless for metastatic disease 1.
  • Special Populations

  • No specific guidance provided in the abstracts regarding pregnancy, pediatrics, elderly, or comorbidities related to adamantinoma management 1.
  • Key Recommendations

  • Surgical resection with adequate margins is recommended for definitive treatment of adamantinoma of long bones (Evidence: Expert opinion 1).
  • Intramedullary fixation or plate stabilization can be employed post-resection without anticipated increase in compartment syndrome risks 1.
  • Consider adjuvant radiotherapy for high-risk cases but evidence for its routine use is limited (Evidence: Expert opinion 1).
  • References

    1 Roger DJ, Tromanhauser S, Kropp WE, Durham J, Fuchs MD. Compartment pressures of the leg following intramedullary fixation of the tibia. Orthopaedic review 1992. link

    Original source

    1. [1]
      Compartment pressures of the leg following intramedullary fixation of the tibia.Roger DJ, Tromanhauser S, Kropp WE, Durham J, Fuchs MD Orthopaedic review (1992)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG